Health
Newly identified biomarker could predict response to immune checkpoint inhibitors – News-Medical.net
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI)…
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.
“Although ICIs revolutionized…
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General21 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General21 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General21 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire